VivoSeq
Other

CHOP

0

Pipeline Programs↗

5

Active Trials↗

2

Companies Involved↗

CHOP is an early-stage landscape with 0 programs across 2 companies. The most active players are Atea Pharmaceuticals, Inc., Macleods Pharmaceuticals Ltd.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Atea Pharmaceuticals, Inc.

0 programs

PreclinicalM

Macleods Pharmaceuticals Ltd

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

20

clinical trials

Completed11 · 55%
Recruiting2 · 10%
Unknown status2 · 10%
Enrolling by invitation1 · 5%
Active, not recruiting1 · 5%
Terminated1 · 5%
Other2 · 10%

Clinical Trials

Trial Activity

20 trials

Psychopharmacotherapy for Depressive Patients
Recruiting·—·N/A·NCT06054321·400 enrolled
CR-CHOP+X in Previously Untreated DEL
Recruiting·RRuijin Hospital·Phase 2·NCT06701357·49 enrolled
Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance
Active, not recruiting·FFondazione Italiana Linfomi - ETS·Phase 2·NCT03731234·75 enrolled
Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd
Not yet recruiting·MMacleods Pharmaceuticals Ltd·Phase 3·NCT06618105·144 enrolled
AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
Enrolling by invitation·TTianjin Medical University Cancer Institute and Hospital·Phase 3·NCT05678933·200 enrolled
MethaCholine Bronchoprovocation Study (MeCIS)
Completed·JJohns Hopkins Bloomberg School of Public Health·Phase 4·NCT00705341·219 enrolled
Psychophysiological Effects of Thorax Wraps With Ginger and Mustard Flour
Completed·—·N/A·NCT02285452·19 enrolled
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab
Completed·UUniversity of Giessen·Phase 3·NCT00991211·549 enrolled
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
Completed·UUniversity of Wisconsin, Madison·Phase 1·NCT00585260·66 enrolled
Human Psychopharmacology of Salvinorin A
Completed·JJohns Hopkins University·Phase 1·NCT00996411·14 enrolled
Psychopharmacotherapy in Multiple Substances Abuse
Completed·NNational Cheng-Kung University Hospital·Phase 3·NCT01189214·200 enrolled
Bronchopulmonary PK of AT-527 (R07496998)
Completed·AAtea Pharmaceuticals, Inc.·Phase 1·NCT04877769·24 enrolled
Mini-CHOP and Rituximab in Patients Aged Over 80 Years
Completed·LLymphoma Study Association·Phase 2·NCT01087424·150 enrolled
Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects
Completed·WWake Forest University·Phase 4·NCT00655811·40 enrolled
Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge
Completed·UUniversity of Saskatchewan·Phase 4·NCT02622243·13 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)